More than 300,000 swab tests have been administered

Oct 19 2020 Share

Following this afternoon’s report of 109 COVID-19 cases overnight, a total of 300,326 swab tests have been administered since the beginning of pandemic in Malta. 

The island currently stands at a total of 1,450 active cases following the Government’s recently imposition of new measures.

109 COVID-19 cases registered overnight with 6 recoveries

62 COVID-19 cases registered overnight with 114 recoveries
Oct 19 2020 Share

Malta has registered 109 new cases of COVID-19 in the past 24 hours from 2,561 swab tests, while 6 patients have recovered. This information was announced by the official Facebook page of Malta’s Ministry for Health.

Today’s cases are still being investigated. From yesterday’s cases; 40 cases were family members of previously known cases, 17 cases were contact of positive work colleagues, 7 cases were direct contacts with other positive cases, 6 cases were from social gatherings with other positive cases and 2 cases were imported.

To date, Malta has registered 4,737 COVID-19 cases in total, of which: 3,242 have recovered, 45 died and 1,450 are still active.


BOV Żabbar branch close temporary following COVID-19 case

Oct 19 2020 Share

Bank of Valletta has advised that its Żabbar branch will be closing temporarily as from today, following a reported COVID-19 case from one of its employees. 

The company has reported that it will be following all guidelines and measures issued by Health Authorities and will be re-opening once they deem the establishment clear.

The Gżira, Marsa and Qormi branches are also currently closed due to the same issues with the Ħamrun branch partially open with certain services.


More than 90,000 flu vaccines administered

Oct 19 2020 Share

Over the past week, the flu vaccine has been given to over 90,000 people across Malta and Gozo. The Department of Health has ordered more than 250,000, of which 100,000 have already arrived.

From tomorrow, the vaccines will be available at Malta’s health centres. The second batch is scheduled to arrive in November, where they will be readily available at health centres and polyclinics.